4Tech said last week that it named a pair of Boston Scientific (NYSE:BSX) veterans as its new CEO and CMO, with onetime chief Mike Ennen stepping away for “family reasons.” Galway, Ireland-based 4Tech said former Boston transcatheter aortic valve GM Tom Fleming is slated to take the reins from Thoratec vet Ennen as president & CEO in […]
imagionbiosystems
Imagion Biosystems raises $9m with Aussie IPO
Imagion Biosystems (ASX:IBX) said today that it raised $9.1 million (A$12 million) in an initial public offering on the Australian stock exchange for its MagSense cancer-tagging nanoparticles. The 15.1¢-per-share (A20¢) flotation of 60 million shares is earmarked for 1st-in-human trials, expected during the 2nd half of 2018, the Albuquerque-based company said. The MagSense nanoparticles have a […]